High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125592 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Antonija Miljak und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Division of Haematology, University Hospital of Split, 21000 Split, Croatia. Hauptthemen laut MEDLINE: B7-H1 Antigen, Hodgkin Disease, Tumor Microenvironment, Macrophages. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Programmed death-ligand 1 (PD-L1) on tumor cells, including Hodgkin and Reed–Sternberg (HRS) cells in classical Hodgkin’s lymphoma (cHL), suppresses immune responses in the tumor immune microenvironment (TME). We analyzed PD-L1 expression in macrophages and HRS cells of 98 cHL cases and correlated the findings with clinicopathological features, overall survival (OS), and progression-free survival (PFS). Epstein–Barr virus (EBV) was detected by in situ hybridization for EBV-encoded RNA. Ten high-power fields were evaluated to count the total number of macrophages and PD-L1+ macrophages, and to calculate PD-L1 histoscore (H-score) in HRS cells. EBV-positive cHL was found in 22.5% of patients. The median H-score was 80 (range 0–300). Bulky disease was associated with a lower number of PD-L1+ macrophages, and extranodal disease with a higher number (p = 0.05). EBV-positive cHL showed a higher PD-L1 H-score in HRS cells and a greater number of PD-L1+ macrophages (p = 0.005); both of these features, along with the proportion of PD-L1+ macrophages, were associated with shorter PFS and OS (p < 0.001). High PD-L1 expression in HRS and macrophages may be linked to worse clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Division of Haematology, University Hospital of Split, 21000 Split, Croatia.
- Department of Pathology, Forensic Medicine and Cytology, University Hospital of Split, 21000 Split, Croatia.
- School of Medicine, University of Split, 21000 Split, Croatia.
ORCID-Profile: Benjamin Benzon, Milan Vujčić
Zitieren
APA
Miljak, A., Pavlović, A., Benzon, B., Čutura, L. V., Galušić, D., Vujčić, M., Blaslov, V., & Durdov, M. G. (2025). High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125592
Vancouver
Miljak A, Pavlović A, Benzon B, Čutura LV, Galušić D, Vujčić M, et al. High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125592
BibTeX
@article{Miljak2025,
author = {Miljak, Antonija and Pavlović, Antonia and Benzon, Benjamin and Čutura, Lučana Vicelić and Galušić, Davor and Vujčić, Milan and Blaslov, Viktor and Durdov, Merica Glavina},
title = {High PD-L1 Expression in HRS Cells and Macrophages in Tumor Immune Microenvironment Is Associated with Adverse Outcome and EBV Positivity in Classical Hodgkin Lymphoma},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125592}
}
EUVIMED